Frances Ashcroft

Dame Frances Mary Ashcroft DBE FRS FMedSci (born 1952) is a British ion channel physiologist.^[4][1][5] She is Royal Society GlaxoSmithKline Research Professor at the University Laboratory of Physiology at the University of Oxford. She is a fellow of Trinity College, Oxford, and is a director of the Oxford Centre for Gene Function. Her research group has an international reputation for work on insulin secretion, type II diabetes and neonatal diabetes.^[6][7] Her work with Andrew Hattersley has helped enable children born with diabetes to switch from insulin injections to tablet therapy.^{[8][9][4][10]}